AustralieFrV1, PascalFrancis, Corpus, bibRecord, 004641

Clinical trials in ovarian carcinoma : requirements for standard approaches and regimens

Identifieur interne : 004641 ( PascalFrancis/Corpus ); précédent : 004640; suivant : 004642

Clinical trials in ovarian carcinoma : requirements for standard approaches and regimens

Auteurs : T. Thigpen ; G. Stuart ; A. Du Bois ; M. Friedlander ; K. Fujiwara ; J. P. Guastalla ; S. Kaye ; H. Kitchener ; G. Kristensen ; R. Mannel ; W. Meier ; B. Miller ; A. Poveda ; D. Provencher ; F. Stehman ; I. Vergote

Source :

Annals of oncology [ 0923-7534 ] ; 2005.

RBID : Pascal:06-0013010

Descripteurs français

Pascal (Inist)
- Essai clinique, Homme, Norme, Carcinome ovaire.

English descriptors

KwdEn :
- Clinical trial, Human, Ovary carcinoma, Standards.

Notice en format standard (ISO 2709)

Pour connaître la documentation sur le format Inist Standard.

A01	`01`	`1`		`@0 0923-7534`
A03		`1`		`@0 Ann. oncol.`
A05				`@2 16`
A06				`@3 SUP8`
A08	`01`	`1`	`ENG`	`@1 Clinical trials in ovarian carcinoma : requirements for standard approaches and regimens`
A09	`01`	`1`	`ENG`	`@1 3rd International Ovarian Cancer Consensus Conference of the GCIG, [September, 2005: Germany]`
A11	`01`	`1`		`@1 THIGPEN (T.)`
A11	`02`	`1`		`@1 STUART (G.)`
A11	`03`	`1`		`@1 DU BOIS (A.)`
A11	`04`	`1`		`@1 FRIEDLANDER (M.)`
A11	`05`	`1`		`@1 FUJIWARA (K.)`
A11	`06`	`1`		`@1 GUASTALLA (J. P.)`
A11	`07`	`1`		`@1 KAYE (S.)`
A11	`08`	`1`		`@1 KITCHENER (H.)`
A11	`09`	`1`		`@1 KRISTENSEN (G.)`
A11	`10`	`1`		`@1 MANNEL (R.)`
A11	`11`	`1`		`@1 MEIER (W.)`
A11	`12`	`1`		`@1 MILLER (B.)`
A11	`13`	`1`		`@1 POVEDA (A.)`
A11	`14`	`1`		`@1 PROVENCHER (D.)`
A11	`15`	`1`		`@1 STEHMAN (F.)`
A11	`16`	`1`		`@1 VERGOTE (I.)`
A12	`01`	`1`		`@1 DU BOIS (A.) @9 ed.`
A12	`02`	`1`		`@1 QUINN (M.) @9 ed.`
A12	`03`	`1`		`@1 THIGPEN (T.) @9 ed.`
A12	`04`	`1`		`@1 VERMORKEN (J. B.) @9 ed.`
A14	`01`			`@1 GOG @3 USA @Z 1 aut. @Z 10 aut. @Z 15 aut.`
A14	`02`			`@1 NCIC-CTG @3 CAN @Z 2 aut. @Z 14 aut.`
A14	`03`			`@1 AGO-OVAR @3 DEU @Z 3 aut. @Z 11 aut.`
A14	`04`			`@1 ANZGOG @3 AUS @Z 4 aut. @Z 13 aut.`
A14	`05`			`@1 JGOG @3 JPN @Z 5 aut.`
A14	`06`			`@1 GINECO @3 FRA @Z 6 aut.`
A14	`07`			`@1 SGCTG @2 Scotland @3 GBR @Z 7 aut.`
A14	`08`			`@1 MRC/NCRI @3 GBR @Z 8 aut.`
A14	`09`			`@1 NSGO @3 INC @Z 9 aut.`
A14	`10`			`@1 RTOG @3 USA @Z 12 aut.`
A14	`11`			`@1 GEICO @3 ESP @Z 13 aut.`
A14	`12`			`@1 EORTC @3 EUR @Z 16 aut.`
A15	`01`			`@1 Department of Gynecology & Gynecologic Oncology, Dr Horst Schmidt Klinik (HSK), Ludwig-Erhard-Str. 100 @2 65199 Wiesbaden @3 DEU @Z 1 aut.`
A15	`02`			`@1 Oncology Unit, Royal Children's Hospital, 132 Grattan Street @2 Carlton, Victoria 3055 @3 AUS @Z 2 aut.`
A15	`03`			`@1 Department of Medicine, Division of Oncology, University of Mississippi Medical Center, 2500 North State Street @2 Jackson, MI 39216 @3 USA @Z 3 aut.`
A15	`04`			`@1 Department of Medical Oncology, University Hospital Antwerp @2 Edegem @3 BEL @Z 4 aut.`
A18	`01`	`1`		`@1 Gynecologic Cancer Intergroup @3 INC @9 org-cong.`
A20				`@2 viii13-viii19`
A21				`@1 2005`
A23	`01`			`@0 ENG`
A43	`01`			`@1 INIST @2 22429 @5 354000135500750010`
A44				`@0 0000 @1 © 2006 INIST-CNRS. All rights reserved.`
A45				`@0 35 ref.`
A47	`01`	`1`		`@0 06-0013010`
A60				`@1 P @2 C`
A61				`@0 A`
A64	`01`	`1`		`@0 Annals of oncology`
A66	`01`			`@0 GBR`
C02	`01`	`X`		`@0 002B02R`
C02	`02`	`X`		`@0 002B20C02`
C03	`01`	`X`	`FRE`	`@0 Essai clinique @5 01`
C03	`01`	`X`	`ENG`	`@0 Clinical trial @5 01`
C03	`01`	`X`	`SPA`	`@0 Ensayo clínico @5 01`
C03	`02`	`X`	`FRE`	`@0 Homme @5 02`
C03	`02`	`X`	`ENG`	`@0 Human @5 02`
C03	`02`	`X`	`SPA`	`@0 Hombre @5 02`
C03	`03`	`X`	`FRE`	`@0 Norme @5 03`
C03	`03`	`X`	`ENG`	`@0 Standards @5 03`
C03	`03`	`X`	`SPA`	`@0 Norma @5 03`
C03	`04`	`X`	`FRE`	`@0 Carcinome ovaire @4 CD @5 96`
C03	`04`	`X`	`ENG`	`@0 Ovary carcinoma @4 CD @5 96`
C03	`04`	`X`	`SPA`	`@0 Carcinoma ovario @4 CD @5 96`
C07	`01`	`X`	`FRE`	`@0 Appareil génital femelle pathologie @5 37`
C07	`01`	`X`	`ENG`	`@0 Female genital diseases @5 37`
C07	`01`	`X`	`SPA`	`@0 Aparato genital hembra patología @5 37`
C07	`02`	`X`	`FRE`	`@0 Ovaire pathologie @5 38`
C07	`02`	`X`	`ENG`	`@0 Ovarian diseases @5 38`
C07	`02`	`X`	`SPA`	`@0 Ovario patología @5 38`
C07	`03`	`X`	`FRE`	`@0 Tumeur maligne @5 39`
C07	`03`	`X`	`ENG`	`@0 Malignant tumor @5 39`
C07	`03`	`X`	`SPA`	`@0 Tumor maligno @5 39`
N21				`@1 002`
N44	`01`			`@1 OTO`
N82				`@1 OTO`

A30	`01`	`1`	`ENG`	`@1 International Ovarian Cancer Consensus Conference @2 3 @3 Baden-Baden DEU @4 2004-09-05`

Format Inist (serveur)

NO :	PASCAL 06-0013010 INIST
ET :	Clinical trials in ovarian carcinoma : requirements for standard approaches and regimens
AU :	THIGPEN (T.); STUART (G.); DU BOIS (A.); FRIEDLANDER (M.); FUJIWARA (K.); GUASTALLA (J. P.); KAYE (S.); KITCHENER (H.); KRISTENSEN (G.); MANNEL (R.); MEIER (W.); MILLER (B.); POVEDA (A.); PROVENCHER (D.); STEHMAN (F.); VERGOTE (I.); DU BOIS (A.); QUINN (M.); THIGPEN (T.); VERMORKEN (J. B.)
AF :	GOG/Etats-Unis (1 aut., 10 aut., 15 aut.); NCIC-CTG/Canada (2 aut., 14 aut.); AGO-OVAR/Allemagne (3 aut., 11 aut.); ANZGOG/Australie (4 aut., 13 aut.); JGOG/Japon (5 aut.); GINECO/France (6 aut.); SGCTG/Scotland/Royaume-Uni (7 aut.); MRC/NCRI/Royaume-Uni (8 aut.); NSGO/Inconnu (9 aut.); RTOG/Etats-Unis (12 aut.); GEICO/Espagne (13 aut.); EORTC/Europe (16 aut.); Department of Gynecology & Gynecologic Oncology, Dr Horst Schmidt Klinik (HSK), Ludwig-Erhard-Str. 100/65199 Wiesbaden/Allemagne (1 aut.); Oncology Unit, Royal Children's Hospital, 132 Grattan Street/Carlton, Victoria 3055/Australie (2 aut.); Department of Medicine, Division of Oncology, University of Mississippi Medical Center, 2500 North State Street/Jackson, MI 39216/Etats-Unis (3 aut.); Department of Medical Oncology, University Hospital Antwerp/Edegem/Belgique (4 aut.)
DT :	Publication en série; Congrès; Niveau analytique
SO :	Annals of oncology; ISSN 0923-7534; Royaume-Uni; Da. 2005; Vol. 16; No. SUP8; viii13-viii19; Bibl. 35 ref.
LA :	Anglais
CC :	002B02R; 002B20C02
FD :	Essai clinique; Homme; Norme; Carcinome ovaire
FG :	Appareil génital femelle pathologie; Ovaire pathologie; Tumeur maligne
ED :	Clinical trial; Human; Standards; Ovary carcinoma
EG :	Female genital diseases; Ovarian diseases; Malignant tumor
SD :	Ensayo clínico; Hombre; Norma; Carcinoma ovario
LO :	INIST-22429.354000135500750010
ID :	06-0013010

Links to Exploration step

Pascal:06-0013010

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Clinical trials in ovarian carcinoma : requirements for standard approaches and regimens</title>
<author><name sortKey="Thigpen, T" sort="Thigpen, T" uniqKey="Thigpen T" first="T." last="Thigpen">T. Thigpen</name>
<affiliation><inist:fA14 i1="01"><s1>GOG</s1>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>10 aut.</sZ>
<sZ>15 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Stuart, G" sort="Stuart, G" uniqKey="Stuart G" first="G." last="Stuart">G. Stuart</name>
<affiliation><inist:fA14 i1="02"><s1>NCIC-CTG</s1>
<s3>CAN</s3>
<sZ>2 aut.</sZ>
<sZ>14 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Du Bois, A" sort="Du Bois, A" uniqKey="Du Bois A" first="A." last="Du Bois">A. Du Bois</name>
<affiliation><inist:fA14 i1="03"><s1>AGO-OVAR</s1>
<s3>DEU</s3>
<sZ>3 aut.</sZ>
<sZ>11 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Friedlander, M" sort="Friedlander, M" uniqKey="Friedlander M" first="M." last="Friedlander">M. Friedlander</name>
<affiliation><inist:fA14 i1="04"><s1>ANZGOG</s1>
<s3>AUS</s3>
<sZ>4 aut.</sZ>
<sZ>13 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Fujiwara, K" sort="Fujiwara, K" uniqKey="Fujiwara K" first="K." last="Fujiwara">K. Fujiwara</name>
<affiliation><inist:fA14 i1="05"><s1>JGOG</s1>
<s3>JPN</s3>
<sZ>5 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Guastalla, J P" sort="Guastalla, J P" uniqKey="Guastalla J" first="J. P." last="Guastalla">J. P. Guastalla</name>
<affiliation><inist:fA14 i1="06"><s1>GINECO</s1>
<s3>FRA</s3>
<sZ>6 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Kaye, S" sort="Kaye, S" uniqKey="Kaye S" first="S." last="Kaye">S. Kaye</name>
<affiliation><inist:fA14 i1="07"><s1>SGCTG</s1>
<s2>Scotland</s2>
<s3>GBR</s3>
<sZ>7 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Kitchener, H" sort="Kitchener, H" uniqKey="Kitchener H" first="H." last="Kitchener">H. Kitchener</name>
<affiliation><inist:fA14 i1="08"><s1>MRC/NCRI</s1>
<s3>GBR</s3>
<sZ>8 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Kristensen, G" sort="Kristensen, G" uniqKey="Kristensen G" first="G." last="Kristensen">G. Kristensen</name>
<affiliation><inist:fA14 i1="09"><s1>NSGO</s1>
<s3>INC</s3>
<sZ>9 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Mannel, R" sort="Mannel, R" uniqKey="Mannel R" first="R." last="Mannel">R. Mannel</name>
<affiliation><inist:fA14 i1="01"><s1>GOG</s1>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>10 aut.</sZ>
<sZ>15 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Meier, W" sort="Meier, W" uniqKey="Meier W" first="W." last="Meier">W. Meier</name>
<affiliation><inist:fA14 i1="03"><s1>AGO-OVAR</s1>
<s3>DEU</s3>
<sZ>3 aut.</sZ>
<sZ>11 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Miller, B" sort="Miller, B" uniqKey="Miller B" first="B." last="Miller">B. Miller</name>
<affiliation><inist:fA14 i1="10"><s1>RTOG</s1>
<s3>USA</s3>
<sZ>12 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Poveda, A" sort="Poveda, A" uniqKey="Poveda A" first="A." last="Poveda">A. Poveda</name>
<affiliation><inist:fA14 i1="04"><s1>ANZGOG</s1>
<s3>AUS</s3>
<sZ>4 aut.</sZ>
<sZ>13 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation><inist:fA14 i1="11"><s1>GEICO</s1>
<s3>ESP</s3>
<sZ>13 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Provencher, D" sort="Provencher, D" uniqKey="Provencher D" first="D." last="Provencher">D. Provencher</name>
<affiliation><inist:fA14 i1="02"><s1>NCIC-CTG</s1>
<s3>CAN</s3>
<sZ>2 aut.</sZ>
<sZ>14 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Stehman, F" sort="Stehman, F" uniqKey="Stehman F" first="F." last="Stehman">F. Stehman</name>
<affiliation><inist:fA14 i1="01"><s1>GOG</s1>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>10 aut.</sZ>
<sZ>15 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Vergote, I" sort="Vergote, I" uniqKey="Vergote I" first="I." last="Vergote">I. Vergote</name>
<affiliation><inist:fA14 i1="12"><s1>EORTC</s1>
<s3>EUR</s3>
<sZ>16 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">06-0013010</idno>
<date when="2005">2005</date>
<idno type="stanalyst">PASCAL 06-0013010 INIST</idno>
<idno type="RBID">Pascal:06-0013010</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">004641</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Clinical trials in ovarian carcinoma : requirements for standard approaches and regimens</title>
<author><name sortKey="Thigpen, T" sort="Thigpen, T" uniqKey="Thigpen T" first="T." last="Thigpen">T. Thigpen</name>
<affiliation><inist:fA14 i1="01"><s1>GOG</s1>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>10 aut.</sZ>
<sZ>15 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Stuart, G" sort="Stuart, G" uniqKey="Stuart G" first="G." last="Stuart">G. Stuart</name>
<affiliation><inist:fA14 i1="02"><s1>NCIC-CTG</s1>
<s3>CAN</s3>
<sZ>2 aut.</sZ>
<sZ>14 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Du Bois, A" sort="Du Bois, A" uniqKey="Du Bois A" first="A." last="Du Bois">A. Du Bois</name>
<affiliation><inist:fA14 i1="03"><s1>AGO-OVAR</s1>
<s3>DEU</s3>
<sZ>3 aut.</sZ>
<sZ>11 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Friedlander, M" sort="Friedlander, M" uniqKey="Friedlander M" first="M." last="Friedlander">M. Friedlander</name>
<affiliation><inist:fA14 i1="04"><s1>ANZGOG</s1>
<s3>AUS</s3>
<sZ>4 aut.</sZ>
<sZ>13 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Fujiwara, K" sort="Fujiwara, K" uniqKey="Fujiwara K" first="K." last="Fujiwara">K. Fujiwara</name>
<affiliation><inist:fA14 i1="05"><s1>JGOG</s1>
<s3>JPN</s3>
<sZ>5 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Guastalla, J P" sort="Guastalla, J P" uniqKey="Guastalla J" first="J. P." last="Guastalla">J. P. Guastalla</name>
<affiliation><inist:fA14 i1="06"><s1>GINECO</s1>
<s3>FRA</s3>
<sZ>6 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Kaye, S" sort="Kaye, S" uniqKey="Kaye S" first="S." last="Kaye">S. Kaye</name>
<affiliation><inist:fA14 i1="07"><s1>SGCTG</s1>
<s2>Scotland</s2>
<s3>GBR</s3>
<sZ>7 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Kitchener, H" sort="Kitchener, H" uniqKey="Kitchener H" first="H." last="Kitchener">H. Kitchener</name>
<affiliation><inist:fA14 i1="08"><s1>MRC/NCRI</s1>
<s3>GBR</s3>
<sZ>8 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Kristensen, G" sort="Kristensen, G" uniqKey="Kristensen G" first="G." last="Kristensen">G. Kristensen</name>
<affiliation><inist:fA14 i1="09"><s1>NSGO</s1>
<s3>INC</s3>
<sZ>9 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Mannel, R" sort="Mannel, R" uniqKey="Mannel R" first="R." last="Mannel">R. Mannel</name>
<affiliation><inist:fA14 i1="01"><s1>GOG</s1>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>10 aut.</sZ>
<sZ>15 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Meier, W" sort="Meier, W" uniqKey="Meier W" first="W." last="Meier">W. Meier</name>
<affiliation><inist:fA14 i1="03"><s1>AGO-OVAR</s1>
<s3>DEU</s3>
<sZ>3 aut.</sZ>
<sZ>11 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Miller, B" sort="Miller, B" uniqKey="Miller B" first="B." last="Miller">B. Miller</name>
<affiliation><inist:fA14 i1="10"><s1>RTOG</s1>
<s3>USA</s3>
<sZ>12 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Poveda, A" sort="Poveda, A" uniqKey="Poveda A" first="A." last="Poveda">A. Poveda</name>
<affiliation><inist:fA14 i1="04"><s1>ANZGOG</s1>
<s3>AUS</s3>
<sZ>4 aut.</sZ>
<sZ>13 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation><inist:fA14 i1="11"><s1>GEICO</s1>
<s3>ESP</s3>
<sZ>13 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Provencher, D" sort="Provencher, D" uniqKey="Provencher D" first="D." last="Provencher">D. Provencher</name>
<affiliation><inist:fA14 i1="02"><s1>NCIC-CTG</s1>
<s3>CAN</s3>
<sZ>2 aut.</sZ>
<sZ>14 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Stehman, F" sort="Stehman, F" uniqKey="Stehman F" first="F." last="Stehman">F. Stehman</name>
<affiliation><inist:fA14 i1="01"><s1>GOG</s1>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>10 aut.</sZ>
<sZ>15 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Vergote, I" sort="Vergote, I" uniqKey="Vergote I" first="I." last="Vergote">I. Vergote</name>
<affiliation><inist:fA14 i1="12"><s1>EORTC</s1>
<s3>EUR</s3>
<sZ>16 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</analytic>
<series><title level="j" type="main">Annals of oncology</title>
<title level="j" type="abbreviated">Ann. oncol.</title>
<idno type="ISSN">0923-7534</idno>
<imprint><date when="2005">2005</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">Annals of oncology</title>
<title level="j" type="abbreviated">Ann. oncol.</title>
<idno type="ISSN">0923-7534</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Clinical trial</term>
<term>Human</term>
<term>Ovary carcinoma</term>
<term>Standards</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Essai clinique</term>
<term>Homme</term>
<term>Norme</term>
<term>Carcinome ovaire</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
</TEI>
<inist><standard h6="B"><pA><fA01 i1="01" i2="1"><s0>0923-7534</s0>
</fA01>
<fA03 i2="1"><s0>Ann. oncol.</s0>
</fA03>
<fA05><s2>16</s2>
</fA05>
<fA06><s3>SUP8</s3>
</fA06>
<fA08 i1="01" i2="1" l="ENG"><s1>Clinical trials in ovarian carcinoma : requirements for standard approaches and regimens</s1>
</fA08>
<fA09 i1="01" i2="1" l="ENG"><s1>3rd International Ovarian Cancer Consensus Conference of the GCIG, [September, 2005: Germany]</s1>
</fA09>
<fA11 i1="01" i2="1"><s1>THIGPEN (T.)</s1>
</fA11>
<fA11 i1="02" i2="1"><s1>STUART (G.)</s1>
</fA11>
<fA11 i1="03" i2="1"><s1>DU BOIS (A.)</s1>
</fA11>
<fA11 i1="04" i2="1"><s1>FRIEDLANDER (M.)</s1>
</fA11>
<fA11 i1="05" i2="1"><s1>FUJIWARA (K.)</s1>
</fA11>
<fA11 i1="06" i2="1"><s1>GUASTALLA (J. P.)</s1>
</fA11>
<fA11 i1="07" i2="1"><s1>KAYE (S.)</s1>
</fA11>
<fA11 i1="08" i2="1"><s1>KITCHENER (H.)</s1>
</fA11>
<fA11 i1="09" i2="1"><s1>KRISTENSEN (G.)</s1>
</fA11>
<fA11 i1="10" i2="1"><s1>MANNEL (R.)</s1>
</fA11>
<fA11 i1="11" i2="1"><s1>MEIER (W.)</s1>
</fA11>
<fA11 i1="12" i2="1"><s1>MILLER (B.)</s1>
</fA11>
<fA11 i1="13" i2="1"><s1>POVEDA (A.)</s1>
</fA11>
<fA11 i1="14" i2="1"><s1>PROVENCHER (D.)</s1>
</fA11>
<fA11 i1="15" i2="1"><s1>STEHMAN (F.)</s1>
</fA11>
<fA11 i1="16" i2="1"><s1>VERGOTE (I.)</s1>
</fA11>
<fA12 i1="01" i2="1"><s1>DU BOIS (A.)</s1>
<s9>ed.</s9>
</fA12>
<fA12 i1="02" i2="1"><s1>QUINN (M.)</s1>
<s9>ed.</s9>
</fA12>
<fA12 i1="03" i2="1"><s1>THIGPEN (T.)</s1>
<s9>ed.</s9>
</fA12>
<fA12 i1="04" i2="1"><s1>VERMORKEN (J. B.)</s1>
<s9>ed.</s9>
</fA12>
<fA14 i1="01"><s1>GOG</s1>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>10 aut.</sZ>
<sZ>15 aut.</sZ>
</fA14>
<fA14 i1="02"><s1>NCIC-CTG</s1>
<s3>CAN</s3>
<sZ>2 aut.</sZ>
<sZ>14 aut.</sZ>
</fA14>
<fA14 i1="03"><s1>AGO-OVAR</s1>
<s3>DEU</s3>
<sZ>3 aut.</sZ>
<sZ>11 aut.</sZ>
</fA14>
<fA14 i1="04"><s1>ANZGOG</s1>
<s3>AUS</s3>
<sZ>4 aut.</sZ>
<sZ>13 aut.</sZ>
</fA14>
<fA14 i1="05"><s1>JGOG</s1>
<s3>JPN</s3>
<sZ>5 aut.</sZ>
</fA14>
<fA14 i1="06"><s1>GINECO</s1>
<s3>FRA</s3>
<sZ>6 aut.</sZ>
</fA14>
<fA14 i1="07"><s1>SGCTG</s1>
<s2>Scotland</s2>
<s3>GBR</s3>
<sZ>7 aut.</sZ>
</fA14>
<fA14 i1="08"><s1>MRC/NCRI</s1>
<s3>GBR</s3>
<sZ>8 aut.</sZ>
</fA14>
<fA14 i1="09"><s1>NSGO</s1>
<s3>INC</s3>
<sZ>9 aut.</sZ>
</fA14>
<fA14 i1="10"><s1>RTOG</s1>
<s3>USA</s3>
<sZ>12 aut.</sZ>
</fA14>
<fA14 i1="11"><s1>GEICO</s1>
<s3>ESP</s3>
<sZ>13 aut.</sZ>
</fA14>
<fA14 i1="12"><s1>EORTC</s1>
<s3>EUR</s3>
<sZ>16 aut.</sZ>
</fA14>
<fA15 i1="01"><s1>Department of Gynecology & Gynecologic Oncology, Dr Horst Schmidt Klinik (HSK), Ludwig-Erhard-Str. 100</s1>
<s2>65199 Wiesbaden</s2>
<s3>DEU</s3>
<sZ>1 aut.</sZ>
</fA15>
<fA15 i1="02"><s1>Oncology Unit, Royal Children's Hospital, 132 Grattan Street</s1>
<s2>Carlton, Victoria 3055</s2>
<s3>AUS</s3>
<sZ>2 aut.</sZ>
</fA15>
<fA15 i1="03"><s1>Department of Medicine, Division of Oncology, University of Mississippi Medical Center, 2500 North State Street</s1>
<s2>Jackson, MI 39216</s2>
<s3>USA</s3>
<sZ>3 aut.</sZ>
</fA15>
<fA15 i1="04"><s1>Department of Medical Oncology, University Hospital Antwerp</s1>
<s2>Edegem</s2>
<s3>BEL</s3>
<sZ>4 aut.</sZ>
</fA15>
<fA18 i1="01" i2="1"><s1>Gynecologic Cancer Intergroup</s1>
<s3>INC</s3>
<s9>org-cong.</s9>
</fA18>
<fA20><s2>viii13-viii19</s2>
</fA20>
<fA21><s1>2005</s1>
</fA21>
<fA23 i1="01"><s0>ENG</s0>
</fA23>
<fA43 i1="01"><s1>INIST</s1>
<s2>22429</s2>
<s5>354000135500750010</s5>
</fA43>
<fA44><s0>0000</s0>
<s1>© 2006 INIST-CNRS. All rights reserved.</s1>
</fA44>
<fA45><s0>35 ref.</s0>
</fA45>
<fA47 i1="01" i2="1"><s0>06-0013010</s0>
</fA47>
<fA60><s1>P</s1>
<s2>C</s2>
</fA60>
<fA61><s0>A</s0>
</fA61>
<fA64 i1="01" i2="1"><s0>Annals of oncology</s0>
</fA64>
<fA66 i1="01"><s0>GBR</s0>
</fA66>
<fC02 i1="01" i2="X"><s0>002B02R</s0>
</fC02>
<fC02 i1="02" i2="X"><s0>002B20C02</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE"><s0>Essai clinique</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG"><s0>Clinical trial</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="SPA"><s0>Ensayo clínico</s0>
<s5>01</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE"><s0>Homme</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG"><s0>Human</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA"><s0>Hombre</s0>
<s5>02</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE"><s0>Norme</s0>
<s5>03</s5>
</fC03>
<fC03 i1="03" i2="X" l="ENG"><s0>Standards</s0>
<s5>03</s5>
</fC03>
<fC03 i1="03" i2="X" l="SPA"><s0>Norma</s0>
<s5>03</s5>
</fC03>
<fC03 i1="04" i2="X" l="FRE"><s0>Carcinome ovaire</s0>
<s4>CD</s4>
<s5>96</s5>
</fC03>
<fC03 i1="04" i2="X" l="ENG"><s0>Ovary carcinoma</s0>
<s4>CD</s4>
<s5>96</s5>
</fC03>
<fC03 i1="04" i2="X" l="SPA"><s0>Carcinoma ovario</s0>
<s4>CD</s4>
<s5>96</s5>
</fC03>
<fC07 i1="01" i2="X" l="FRE"><s0>Appareil génital femelle pathologie</s0>
<s5>37</s5>
</fC07>
<fC07 i1="01" i2="X" l="ENG"><s0>Female genital diseases</s0>
<s5>37</s5>
</fC07>
<fC07 i1="01" i2="X" l="SPA"><s0>Aparato genital hembra patología</s0>
<s5>37</s5>
</fC07>
<fC07 i1="02" i2="X" l="FRE"><s0>Ovaire pathologie</s0>
<s5>38</s5>
</fC07>
<fC07 i1="02" i2="X" l="ENG"><s0>Ovarian diseases</s0>
<s5>38</s5>
</fC07>
<fC07 i1="02" i2="X" l="SPA"><s0>Ovario patología</s0>
<s5>38</s5>
</fC07>
<fC07 i1="03" i2="X" l="FRE"><s0>Tumeur maligne</s0>
<s5>39</s5>
</fC07>
<fC07 i1="03" i2="X" l="ENG"><s0>Malignant tumor</s0>
<s5>39</s5>
</fC07>
<fC07 i1="03" i2="X" l="SPA"><s0>Tumor maligno</s0>
<s5>39</s5>
</fC07>
<fN21><s1>002</s1>
</fN21>
<fN44 i1="01"><s1>OTO</s1>
</fN44>
<fN82><s1>OTO</s1>
</fN82>
</pA>
<pR><fA30 i1="01" i2="1" l="ENG"><s1>International Ovarian Cancer Consensus Conference</s1>
<s2>3</s2>
<s3>Baden-Baden DEU</s3>
<s4>2004-09-05</s4>
</fA30>
</pR>
</standard>
<server><NO>PASCAL 06-0013010 INIST</NO>
<ET>Clinical trials in ovarian carcinoma : requirements for standard approaches and regimens</ET>
<AU>THIGPEN (T.); STUART (G.); DU BOIS (A.); FRIEDLANDER (M.); FUJIWARA (K.); GUASTALLA (J. P.); KAYE (S.); KITCHENER (H.); KRISTENSEN (G.); MANNEL (R.); MEIER (W.); MILLER (B.); POVEDA (A.); PROVENCHER (D.); STEHMAN (F.); VERGOTE (I.); DU BOIS (A.); QUINN (M.); THIGPEN (T.); VERMORKEN (J. B.)</AU>
<AF>GOG/Etats-Unis (1 aut., 10 aut., 15 aut.); NCIC-CTG/Canada (2 aut., 14 aut.); AGO-OVAR/Allemagne (3 aut., 11 aut.); ANZGOG/Australie (4 aut., 13 aut.); JGOG/Japon (5 aut.); GINECO/France (6 aut.); SGCTG/Scotland/Royaume-Uni (7 aut.); MRC/NCRI/Royaume-Uni (8 aut.); NSGO/Inconnu (9 aut.); RTOG/Etats-Unis (12 aut.); GEICO/Espagne (13 aut.); EORTC/Europe (16 aut.); Department of Gynecology & Gynecologic Oncology, Dr Horst Schmidt Klinik (HSK), Ludwig-Erhard-Str. 100/65199 Wiesbaden/Allemagne (1 aut.); Oncology Unit, Royal Children's Hospital, 132 Grattan Street/Carlton, Victoria 3055/Australie (2 aut.); Department of Medicine, Division of Oncology, University of Mississippi Medical Center, 2500 North State Street/Jackson, MI 39216/Etats-Unis (3 aut.); Department of Medical Oncology, University Hospital Antwerp/Edegem/Belgique (4 aut.)</AF>
<DT>Publication en série; Congrès; Niveau analytique</DT>
<SO>Annals of oncology; ISSN 0923-7534; Royaume-Uni; Da. 2005; Vol. 16; No. SUP8; viii13-viii19; Bibl. 35 ref.</SO>
<LA>Anglais</LA>
<CC>002B02R; 002B20C02</CC>
<FD>Essai clinique; Homme; Norme; Carcinome ovaire</FD>
<FG>Appareil génital femelle pathologie; Ovaire pathologie; Tumeur maligne</FG>
<ED>Clinical trial; Human; Standards; Ovary carcinoma</ED>
<EG>Female genital diseases; Ovarian diseases; Malignant tumor</EG>
<SD>Ensayo clínico; Hombre; Norma; Carcinoma ovario</SD>
<LO>INIST-22429.354000135500750010</LO>
<ID>06-0013010</ID>
</server>
</inist>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/PascalFrancis/Corpus

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 004641 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Corpus/biblio.hfd -nk 004641 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Asie
   |area=    AustralieFrV1
   |flux=    PascalFrancis
   |étape=   Corpus
   |type=    RBID
   |clé=     Pascal:06-0013010
   |texte=   Clinical trials in ovarian carcinoma : requirements for standard approaches and regimens
}}

This area was generated with Dilib version V0.6.33.
Data generation: Tue Dec 5 10:43:12 2017. Site generation: Tue Mar 5 14:07:20 2024

	Serveur d'exploration sur les relations entre la France et l'Australie
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration sur les relations entre la France et l'Australie

Clinical trials in ovarian carcinoma : requirements for standard approaches and regimens

Clinical trials in ovarian carcinoma : requirements for standard approaches and regimens

Source :

Descripteurs français

English descriptors

Notice en format standard (ISO 2709)

Format Inist (serveur)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri